The forecasted data for 2024 to 2028 indicates a steady increase in the total number of 10% top-cited scientific publications in biochemistry, genetics, and molecular biology in the US. Starting at 5.34 thousand publications in 2024, the value rises incrementally each year, reaching 5.67 thousand by 2028. When examining year-on-year variations, a consistent upward trend is apparent, with annual growth rates indicative of positive development in this academic domain. The compound annual growth rate (CAGR) over the five-year period averages a small but steady upward trajectory, hinting at continual improvement in citation impact.
Future trends to watch for include technological advancements in molecular research, increased interdisciplinary collaborations, and enhanced funding initiatives, all of which could significantly impact the volume and impact of top-cited publications. Additionally, shifts in publication process norms and open-access policies might also influence these future outcomes.
